Showing results (91-100 of 153) with videos related to

Sort By:
Pageof 16
The Journal of Physiology|November 10, 2010
Free radical signalling underlies inhibition of CaV3.2 T-type calcium channels by nitrous oxide in the pain pathwayPeihan Orestes, Damir Bojadzic, Jeonghan Lee, et al.
Neuropharmacology|March 27, 2018
CaV3.1 isoform of T-type calcium channels supports excitability of rat and mouse ventral tegmental area neuronsMatthew E Tracy, Vesna Tesic, Tamara Timic Stamenic, et al.
Acta Chirurgica Iugoslavica|June 8, 2004
[Medullary carcinoma of the thyroid gland (sporadic, familial)]I Paunović, A Diklić, K Krgović, et al.
Frontiers in Pharmacology|June 9, 2022
Further Evidence that Inhibition of Neuronal Voltage-Gated Calcium Channels Contributes to the Hypnotic Effect of Neurosteroid Analogue, 3β-OHTamara Timic Stamenic, Francesca M Manzella, Stefan Maksimovic, et al.
Die Pharmazie|October 16, 2024
Comparison of pharmacotherapeutic analgesic response and safety profile of tapentadol with other opioidsD Krtinic, G N Rankovic, A Cvetanovic, et al.
International Journal of Molecular Sciences|May 7, 2025
Role of Thalamic CaV3.1 T-Channels in Fear ConditioningTamara Timic Stamenic, Srdjan M Joksimovic, Brier Fine-Raquet, et al.
Frontiers in Cellular Neuroscience|January 1, 2021
Glycosylation of CaV3.2 Channels Contributes to the Hyperalgesia in Peripheral Neuropathy of Type 1 DiabetesSonja Lj Joksimovic, J Grayson Evans, William E McIntire, et al.
Molecular Pharmacology|August 9, 2011
TTA-P2 is a potent and selective blocker of T-type calcium channels in rat sensory neurons and a novel antinociceptive agentWonjoo Choe, Richard B Messinger, Emily Leach, et al.
Pageof 16